1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Gilquin, B.
Roumestand, C.
Zinn-Justin, S.
Menez, A.
Toma, F.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Biopolymers
BIPMAA
0161
0006-3525
33
1659
1675
10.1002/bip.360331104
8241426
Refined three-dimensional solution structure of a snake cardiotoxin: analysis of the side-chain organization suggests the existence of a possible phospholipid binding site.
1993
To be Published
0353
Proton NMR Studies of the Structural and Dynamical Effects of Chemical Modification of Single Aromatic Side Chain in a Snake Cardiotoxin: Relation with the Structure of the Putative Binding Site and the Cytolitic Activity of the Toxin
10.2210/pdb1cxn/pdb
pdb_00001cxn
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
6838.462
CARDIOTOXIN GAMMA
1
man
polymer
no
no
LKCNQLIPPFWKTCPKGKNLCYKMTMRAAPMVPVKRGCIDVCPKSSLLIKYMCCNTDKCN
LKCNQLIPPFWKTCPKGKNLCYKMTMRAAPMVPVKRGCIDVCPKSSLLIKYMCCNTDKCN
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
spitting cobra
Naja
sample
8654
Naja nigricollis
database_2
pdbx_database_status
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
Other
1
0
1994-12-20
1
1
2008-03-24
1
2
2011-07-13
1
3
2022-02-16
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.process_site
Y
BNL
1994-07-08
REL
1
BRUNGER
refinement
X-PLOR
LEU
1
n
1
LEU
1
A
LYS
2
n
2
LYS
2
A
CYS
3
n
3
CYS
3
A
ASN
4
n
4
ASN
4
A
GLN
5
n
5
GLN
5
A
LEU
6
n
6
LEU
6
A
ILE
7
n
7
ILE
7
A
PRO
8
n
8
PRO
8
A
PRO
9
n
9
PRO
9
A
PHE
10
n
10
PHE
10
A
TRP
11
n
11
TRP
11
A
LYS
12
n
12
LYS
12
A
THR
13
n
13
THR
13
A
CYS
14
n
14
CYS
14
A
PRO
15
n
15
PRO
15
A
LYS
16
n
16
LYS
16
A
GLY
17
n
17
GLY
17
A
LYS
18
n
18
LYS
18
A
ASN
19
n
19
ASN
19
A
LEU
20
n
20
LEU
20
A
CYS
21
n
21
CYS
21
A
TYR
22
n
22
TYR
22
A
LYS
23
n
23
LYS
23
A
MET
24
n
24
MET
24
A
THR
25
n
25
THR
25
A
MET
26
n
26
MET
26
A
ARG
27
n
27
ARG
27
A
ALA
28
n
28
ALA
28
A
ALA
29
n
29
ALA
29
A
PRO
30
n
30
PRO
30
A
MET
31
n
31
MET
31
A
VAL
32
n
32
VAL
32
A
PRO
33
n
33
PRO
33
A
VAL
34
n
34
VAL
34
A
LYS
35
n
35
LYS
35
A
ARG
36
n
36
ARG
36
A
GLY
37
n
37
GLY
37
A
CYS
38
n
38
CYS
38
A
ILE
39
n
39
ILE
39
A
ASP
40
n
40
ASP
40
A
VAL
41
n
41
VAL
41
A
CYS
42
n
42
CYS
42
A
PRO
43
n
43
PRO
43
A
LYS
44
n
44
LYS
44
A
SER
45
n
45
SER
45
A
SER
46
n
46
SER
46
A
LEU
47
n
47
LEU
47
A
LEU
48
n
48
LEU
48
A
ILE
49
n
49
ILE
49
A
LYS
50
n
50
LYS
50
A
TYR
51
n
51
TYR
51
A
MET
52
n
52
MET
52
A
CYS
53
n
53
CYS
53
A
CYS
54
n
54
CYS
54
A
ASN
55
n
55
ASN
55
A
THR
56
n
56
THR
56
A
ASP
57
n
57
ASP
57
A
LYS
58
n
58
LYS
58
A
CYS
59
n
59
CYS
59
A
ASN
60
n
60
ASN
60
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
CYS
3
A
N
CYS
3
A
O
LYS
12
A
O
LYS
12
A
O
ILE
39
A
O
ILE
39
A
N
LEU
20
A
N
LEU
20
A
O
THR
25
A
O
THR
25
A
N
LYS
50
A
N
LYS
50
1
-5.33
0.70
120.80
115.47
A
A
A
CB
CG
CD2
PHE
PHE
PHE
10
10
10
N
1
-7.24
1.00
110.10
102.86
A
A
A
CG
CD1
NE1
TRP
TRP
TRP
11
11
11
N
1
8.08
0.90
109.00
117.08
A
A
A
CD1
NE1
CE2
TRP
TRP
TRP
11
11
11
N
1
9.44
1.10
130.40
139.84
A
A
A
NE1
CE2
CZ2
TRP
TRP
TRP
11
11
11
N
1
-6.30
1.00
107.30
101.00
A
A
A
NE1
CE2
CD2
TRP
TRP
TRP
11
11
11
N
1
A
A
CA
CB
LYS
LYS
18
18
-0.146
0.022
1.535
1.389
N
1
A
GLN
5
-89.51
-118.47
1
A
LEU
6
-64.35
-113.16
1
A
PRO
9
-51.46
75.67
1
A
PRO
30
-61.20
-70.54
1
A
MET
31
-155.75
65.63
1
A
PRO
33
-66.61
96.23
1
A
VAL
34
-90.88
-70.78
1
A
ILE
39
-134.62
-157.76
1
A
ASP
40
-121.92
-62.63
1
A
LYS
58
67.60
-24.75
model building
X-PLOR
refinement
X-PLOR
phasing
X-PLOR
REFINED THREE-DIMENSIONAL SOLUTION STRUCTURE OF A SNAKE CARDIOTOXIN: ANALYSIS OF THE SIDE-CHAIN ORGANISATION SUGGESTS THE EXISTENCE OF A POSSIBLE PHOSPHOLIPID BINDING SITE
1
Y
N
disulf
2.015
A
CYS
3
A
SG
CYS
3
1_555
A
CYS
21
A
SG
CYS
21
1_555
disulf
2.021
A
CYS
14
A
SG
CYS
14
1_555
A
CYS
38
A
SG
CYS
38
1_555
disulf
2.015
A
CYS
42
A
SG
CYS
42
1_555
A
CYS
53
A
SG
CYS
53
1_555
disulf
2.017
A
CYS
54
A
SG
CYS
54
1_555
A
CYS
59
A
SG
CYS
59
1_555
CYTOTOXIN
CYTOTOXIN
CX1_NAJPA
UNP
1
1
P01468
LKCNQLIPPFWKTCPKGKNLCYKMTMRAAPMVPVKRGCIDVCPKSSLLIKYMCCNTDKCN
1
60
1CXN
1
60
P01468
A
1
1
60
2
3
anti-parallel
anti-parallel
anti-parallel
A
LYS
2
A
LYS
2
A
ASN
4
A
ASN
4
A
TRP
11
A
TRP
11
A
THR
13
A
THR
13
A
VAL
32
A
VAL
32
A
ILE
39
A
ILE
39
A
LEU
20
A
LEU
20
A
MET
26
A
MET
26
A
ILE
49
A
ILE
49
A
CYS
54
A
CYS
54
1
P 1